Methods and compositions containing mtor inhibitors for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/14 (2006.01) A61K 31/436 (2006.01) A61K 39/39 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2748931

Provided are compositions and methods for enhancing immune responses to an antigen. The compositions contain an isolated population of CD8+ T cells and an inhibitor of mammalian target of rapamycin (mTOR). The method for obtaining an enhanced immune response to an antigen in an individual entails administering to the individual the antigen and an inhibitor of mammalian target of rapamycin (mTOR). CD8+ T cells may also be used for adoptive cell transfer (ACT) therapy.

L'invention porte sur des compositions et sur des procédés pour améliorer les réponses immunitaires à un antigène. Les compositions contiennent une population isolée de lymphocytes T CD8+ et un inhibiteur de la cible mammifère de rapamycine (mTOR). Le procédé pour obtenir une réponse immunitaire améliorée à un antigène chez un individu comprend l'administration à l'individu de l'antigène et d'un inhibiteur de la cible mammifère de rapamycine (mTOR). Des lymphocytes T CD8+ peuvent également être utilisés pour une thérapie à transfert adoptif de lymphocytes (ACT).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions containing mtor inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions containing mtor inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions containing mtor inhibitors for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1842148

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.